Hui-Na Wang Selected Research

Oxazolone

1/2021

Inhibition of c-Fos expression attenuates IgE-mediated mast cell activation and allergic inflammation by counteracting an inhibitory AP1/Egr1/IL-4 axis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui-Na Wang Research Topics

Disease

4	Anaphylaxis (Anaphylactic Shock) 03/2022 - 07/2020
4	Inflammation (Inflammations) 03/2022 - 01/2021
3	Hypersensitivity (Allergy) 03/2022 - 07/2020
2	Leukemia 03/2022 - 02/2022
2	Adenocarcinoma of Lung 01/2022 - 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Rubella (German Measles) 01/2018

Drug/Important Bio-Agent (IBA)

4	OvalbuminIBA 03/2022 - 07/2020
4	Immunoglobulin E (IgE)IBA 03/2022 - 01/2021
2	Human Serum Albumin FDA LinkGeneric 03/2022 - 02/2022
2	AntibodiesIBA 03/2022 - 02/2022
2	Immunoglobulins (Immunoglobulin)IBA 03/2022 - 02/2022
2	Coloring Agents (Dyes)IBA 03/2022 - 02/2022
2	pralsetinibIBA 01/2022 - 01/2022
1	Histamine (Histamine Dihydrochloride)FDA Link 03/2022
1	AntigensIBA 03/2022
1	Flavoring AgentsIBA 03/2022
1	HymecromoneIBA 02/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	3- (5- (4- (cyclopentyloxy)- 2- hydroxybenzoyl)- 2- ((3- hydroxy- 1,2- benzisoxazol- 6- yl)methoxy)phenyl)propionic acidIBA 01/2021
1	OxazoloneIBA 01/2021
1	Pimozide (Orap)FDA Link 07/2020
1	ChromatinIBA 01/2018